Home > Boards > US Listed > Medical - Equipment > Obalon Therapeutics, Inc. (OBLN)

ER should be interesting, if only to see

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
r clarke Member Profile
 
Followed By 11
Posts 2,796
Boards Moderated 1
Alias Born 11/16/13
160x600 placeholder
Obalon Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System GlobeNewswire Inc. - 7/16/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2019 4:52:01 PM
Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt GlobeNewswire Inc. - 7/10/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2019 4:10:14 PM
Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Devi... GlobeNewswire Inc. - 6/24/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 6:02:09 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 6/21/2019 5:24:09 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/13/2019 4:08:23 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/13/2019 4:03:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 12:28:00 PM
Obalon Appoints Bob MacDonald as Chief Retail Officer GlobeNewswire Inc. - 6/10/2019 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/7/2019 5:05:43 PM
Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System GlobeNewswire Inc. - 6/4/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 7:16:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/3/2019 7:16:05 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/31/2019 5:31:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2019 5:12:26 PM
Under the Radar Biotechs To Research Now InvestorsHub NewsWire - 5/30/2019 1:40:00 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/30/2019 6:09:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/30/2019 6:05:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2019 5:23:42 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/28/2019 6:05:25 AM
Obalon Therapeutics, Inc. Prices $3,000,000 Registered Direct Offering GlobeNewswire Inc. - 5/23/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2019 4:52:11 PM
Expanded Clinical Data Set for the Obalon Balloon System Presented at DDW 2019 GlobeNewswire Inc. - 5/21/2019 4:01:00 PM
r clarke   Friday, 05/03/19 10:07:51 PM
Re: None
Post # of 351 
ER should be interesting, if only to see if management actually has a plan in mind.

I think the exodus will continue, and the company will lose some real talent.

Glass Door had some interesting takes:



Apr 3, 2019
Helpful (1)
Obalon Therapeutics Logo
"Horrible Management"
Current Employee - Anonymous Employee in Carlsbad, CA
Doesn't Recommend
Negative Outlook
Disapproves of CEO
I have been working at Obalon Therapeutics full-time for more than 4 years

Pros

Pros, Absolutely none, horrible company.

Cons

They Dont care about their employees, they laid off more than half of the company just like that, no warning, right after they worked everyone like slaves, horrible pay, The VP is a absolute BUST he is a micromanager hes down everyone's back all day he has absolutely no trust in anyone. He has No idea what hes doing. They do not give raises. Ungrateful company!

--


Cons

Overly focused, $$$ spent on Marketing and Sales Operations not developed / staffed to support company growth Product quality / manufacturability not sustainable enough to become profitable

Advice to Management

You've lost or pushed out a lot of talent due to a top heavy, largely ineffective executive management team. Reduce the number of VP's and invest in middle mgmt. and professional level employees to advance operations and support company growth if your sales ever come back.


===


an 22, 2019
Obalon Therapeutics Logo
"New CEO is a Bust"
Current Employee - Anonymous Employee
Doesn't Recommend
Negative Outlook
I have been working at Obalon Therapeutics full-time

Pros

None that come to mind

Cons

New CEO is not trustworthy or experienced, a warm body to fill a chair.

Advice to Management

Reboot with an new CEO


===

Cons

Poor management, leadership changes direction too often, management makes poor decisions.

Advice to Management

Replace managers with people who know how to manage a team and know what they're doing. Take care of the customer and your employees.


-----



"Negative Environment, Poor Leadership, Not Customer Centric"



Cons

Management doesn't care about the customer, only about closing deals. Low moral. Negative environment and so unethical. Bonus structures are inconsistent. Managers are dishonest to both the employees and customers. Leadership has no clue what they're doing.

Advice to Management

Go back to the drawing board and start over. Replace managers with people who know how to manage a team and know what they're doing. Take care of the customer and your employees.






Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist